Menu

Zenas BioPharma, Inc. ZBIO

Full chart Compare
Set alert

Price alert · ZBIO

All alert types
28.26 USD +2.33 (+8.99%)

At closeNov 6, 2026, 4:00 PM EST

28.26 0.00 0.00%

After hours · Nov 6, 4:00 PM ET

25.94 Day range 28.44
13.50 52-week range 44.60
YTD
-22.17%
1 year
-12.94%

Revenue & Expenses

Income Tax Benefit → Expenses: $79.00KExpenses → Selling, General & Admin: $53.32MExpenses → Research & Development: $168.06MExpenses → Interest Expense: $7.33MExpenses → Other Expenses: $159.10MGross Profit → Expenses: $10.00MRevenue → Gross Profit: $10.00MNet Loss → Expenses: $377.74MIncome Tax Benefit$79.00KGross Profit$10.00MNet Loss$377.74MExpenses$387.82MSelling, General & Admin$53.32MResearch & Development$168.06MInterest Expense$7.33MOther Expenses$159.10MRevenue$10.00M

Latest period ending Dec 31, 2025 · select a line to chart its full history

ZBIO annual income statement
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022
10.00M5.00M50.00M0
10.00M5.00M50.00M0
-383.06M-163.89M-37.15M-76.20M
-377.74M-156.99M-37.12M-119.28M
-8.44-11.89-24.25-9.21
ZBIO annual balance sheet
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022
110.64M319.83M56.94M67.30M
383.64M369.97M68.18M74.58M
141.50M57.51M43.81M26.78M
1.33M1.00M21.11M1.53M
242.14M312.46M-225.72M-192.29M
ZBIO annual cash flow
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022
-172.33M-119.67M-30.53M-65.65M
-251.89M-30.55M-17.00K-2.20M
215.28M412.96M20.12M59.39M
-18.00K-131.00K-17.00K-2.20M
-209.19M262.89M-10.35M-8.50M